相关临床试验
57
19 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1986
进行中（未招募）
1
1.8%
已完成
22
38.6%
尚未招募
18
31.6%
招募中
7
12.3%
终止
1
1.8%
Unknown
8
14.0%
暂无批准数据
- Dr. Anwaar Said Al Maqbali at Sultan Qaboos University synthesized a new series of chiral triazoline compounds with carbohydrate-based appendages using 1,3-dipolar cycloaddition. - Selected compounds demonstrated strong biological activity across 60 cancer cell lines, with certain derivatives showing high effectiveness specifically against leukemia cells. - Promising anti-fungal and anti-bacterial properties were also observed, suggesting potential as versatile therapeutic agents. - The research won the 12th National Research Award in Oman and was published in the journal *Molecules*.
- The University Medical City in Oman successfully implemented the first CAR-T cell therapy in the Sultanate, positioning the country among regional leaders in advanced blood cancer treatment. - The therapy has demonstrated remarkable response rates in patients with B-cell Acute Lymphoblastic Leukemia and Diffuse Large B-cell Lymphoma, particularly for those unresponsive to conventional treatments. - This achievement results from collaboration between national medical teams and international partners, marking a significant step toward medical self-sufficiency and reduced overseas treatment costs. - The implementation represents a pioneering milestone in localizing cutting-edge immunotherapy previously available only at select international centers.
